Long-term outcomes of left bundle branch area pacing compared with right ventricular pacing in TAVI patients
Xi Wang,Yuanning Xu,Lijun Zeng,Kun Tan,Xueli Zhang,Xu Han,Tianyuan Xiong,Zhengang Zhao,Yong Peng,Jiafu Wei,Qiao Li,Sen He,Yong Chen,Minggang Zhou,Xi Li,Xin Wei,Yujia Liang,Wenxia Zhou,Lingyun Jiang,Xingbin Liu,Wei Meng,Rui Zhou,Guojun Xiong,Min Dai,Xiaojian Deng,Yuan Feng,Mao Chen
DOI: https://doi.org/10.1016/j.hrthm.2024.09.021
IF: 6.779
2024-09-15
Heart Rhythm
Abstract:Background: New-onset permanent pacemaker implantation (PPMI) is still a common complication after transcatheter aortic valve implantation (TAVI) with adverse clinical outcomes. Objective: The purpose of this study was to investigate whether left bundle branch area pacing (LBBAP) improves long-term clinical results compared with traditional right ventricular pacing (RVP) in patients requiring PPMI after TAVI. Methods: A total of 237 consecutive patients undergoing RVP (N = 117) or LBBAP (N = 120) after TAVI were retrospectively included. Long-term outcomes, including all-cause death, heart failure rehospitalization (HFH), and left ventricular ejection fraction (LVEF) change compared to baseline, were obtained until 5 years post-TAVI. Results: The mean age of the overall population was 74 years, with a mean surgical risk score of 4.4%. The paced QRS duration was significantly longer in the RVP group compared with the LBBAP group (151 ± 18 vs 122 ± 12 ms; P < .001). No difference was found between the 2 groups in all-cause death (13.7% vs 13.3%; adjusted hazard ratio [HR], 0.76; 95% confidence interval [CI], 0.37-1.58; P = .466) or the composite endpoint of death and HFH (29.9% vs 19.2%; adjusted HR, 1.22; 95% CI, 0.70-2.13; P = .476); however, the risk of HFH was significantly higher in the RVP group at 5 years after TAVI (21.4% vs 7.5%; adjusted HR, 2.26; 95% CI, 1.01-5.08; P = .048). There was greater improvement of LVEF over time in the LBBAP group (P = .046 for LVEF changes over time between groups). Conclusions: LBBAP improved long-term clinical outcomes compared with RVP in patients undergoing PPMI after TAVI in terms of less HFH and better LVEF improvement.